Harr Hematology Practice Test

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that primarily affects blood vessels, leading to the abnormal formation of small blood vessels called telangiectasias. These blood vessels are fragile and can easily break, resulting in nosebleeds, gastrointestinal bleeding, and other hemorrhagic complications. The underlying issue in HHT is related to defects in the connective tissue that supports and stabilizes blood vessels. This affects the integrity and structure of the vascular system, which is essential for maintaining normal hemostasis. In contrast, disorders linked to platelets involve abnormalities in platelet function or count, while disorders involving clotting proteins pertain to issues with specific factors in the coagulation cascade. Fibrinolysis refers to the process of breaking down fibrin in blood clots, which is not the primary issue in HHT. Therefore, the classification of hereditary hemorrhagic telangiectasia as a disorder of connective tissue reflects the fundamental nature of the vascular anomalies seen in this condition.